Chinese General Practice ›› 2022, Vol. 25 ›› Issue (08): 973-978.DOI: 10.12114/j.issn.1007-9572.2021.01.041
Special Issue: 儿科最新文章合辑; 泌尿系统疾病最新文章合辑
• Original Research • Previous Articles Next Articles
Is the Change of Cytokines Related to Renal Damage in Children with IgA Vasculitis?
Department of Pediatrics,Shengjing Hospital of China Medical University,Shenyang 110000,China
*Corresponding author:DU Yue,Professor;E-mail:duy @sj-hospital.org
Received:
2021-06-23
Revised:
2021-11-14
Published:
2022-03-15
Online:
2022-03-02
通讯作者:
杜悦
CLC Number:
WANG Mengdi, DU Yue.
Is the Change of Cytokines Related to Renal Damage in Children with IgA Vasculitis? [J]. Chinese General Practice, 2022, 25(08): 973-978.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2021.01.041
组别 | 例数 | 性别(男/女) | 年龄〔M(P25,P75),岁〕 |
---|---|---|---|
对照组 | 60 | 28/32 | 8(6,9) |
IgAV肾损害组 | 97 | 54/43 | 8(6,10) |
IgAV组 | 97 | 57/40 | 7(6,10) |
χ2(H)值 | 2.246 | 2.817a | |
P值 | 0.325 | 0.245 |
Table 1 Comparison of age and sex among IgAV renal damage group,IgAV group,and control group
组别 | 例数 | 性别(男/女) | 年龄〔M(P25,P75),岁〕 |
---|---|---|---|
对照组 | 60 | 28/32 | 8(6,9) |
IgAV肾损害组 | 97 | 54/43 | 8(6,10) |
IgAV组 | 97 | 57/40 | 7(6,10) |
χ2(H)值 | 2.246 | 2.817a | |
P值 | 0.325 | 0.245 |
组别 | 例数 | IL-2 | IL-4 | IL-6 | IL-10 | IL-17 | IFN-γ | TNF-α |
---|---|---|---|---|---|---|---|---|
对照组 | 60 | 0.78(0.60,1.02) | 1.39(1.14,1.80) | 2.77(1.84,5.54) | 1.98(1.56,2.30) | 6.97(5.95,9.10) | 1.43(1.17,1.7) | 1.425(1.1,1.88) |
IgAV肾损害组 | 97 | 0.99(0.71,1.28)a | 1.79(1.38,2.24) | 2.29(1.75,3.89) | 2.07(1.61,2.85) | 10.62(7.47,14.06)a | 1.35(1.09,1.68) | 1.61(1.25,1.98) |
IgAV组 | 97 | 1.16(0.84,1.50)ab | 1.56(1.22,2.11) | 3.82(2.43,6.58)ab | 2.71(2.08,3.68)ab | 8.97(6.62,10.75)ab | 1.03(0.81,1.32)ab | 1.86(1.45,2.37)ab |
H值 | 25.759 | 12.517 | 19.941 | 37.234 | 28.236 | 33.495 | 17.363 | |
P值 | <0.001 | 0.200 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 |
Table 2 Comparison of cytokines among IgAV renal damage,IgAV,and control groups
组别 | 例数 | IL-2 | IL-4 | IL-6 | IL-10 | IL-17 | IFN-γ | TNF-α |
---|---|---|---|---|---|---|---|---|
对照组 | 60 | 0.78(0.60,1.02) | 1.39(1.14,1.80) | 2.77(1.84,5.54) | 1.98(1.56,2.30) | 6.97(5.95,9.10) | 1.43(1.17,1.7) | 1.425(1.1,1.88) |
IgAV肾损害组 | 97 | 0.99(0.71,1.28)a | 1.79(1.38,2.24) | 2.29(1.75,3.89) | 2.07(1.61,2.85) | 10.62(7.47,14.06)a | 1.35(1.09,1.68) | 1.61(1.25,1.98) |
IgAV组 | 97 | 1.16(0.84,1.50)ab | 1.56(1.22,2.11) | 3.82(2.43,6.58)ab | 2.71(2.08,3.68)ab | 8.97(6.62,10.75)ab | 1.03(0.81,1.32)ab | 1.86(1.45,2.37)ab |
H值 | 25.759 | 12.517 | 19.941 | 37.234 | 28.236 | 33.495 | 17.363 | |
P值 | <0.001 | 0.200 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 |
组别 | 例数 | 总T淋巴细胞(%) | Th/Ts | NK〔M(P25,P75),%〕 | 总B淋巴细胞〔M(P25,P75),%〕 | 总T绝对数〔M(P25,P75)〕 | NK总数〔M(P25,P75)〕 | 总B淋巴细胞计数〔M(P25,P75)〕 | IgA〔M(P25,P75),g/L〕 | IgE 〔M(P25,P75),g/L〕 |
---|---|---|---|---|---|---|---|---|---|---|
IgAV肾损害组 | 97 | 63.6±10.2 | 1.07(0.78,1.32) | 11.30(7.90,18.00) | 21.10(16.19,26.60) | 1 262(843,1 762) | 228(138,362) | 371(260,609) | 2.60(1.93,3.28) | 82.85(29.59,173.50) |
IgAV组 | 97 | 59.4±9.3 | 0.97(0.81,1.30) | 12.45(8.10,18.97) | 25.55(19.53,31.10) | 1 156(724,1 420) | 209(156,333) | 453(324,618) | 2.05(1.53,2.74) | 66.55(32.89,180.00) |
u(t)值 | 3.030a | -0.453 | -0.803 | -3.375 | -1.917 | -0.254 | -1.260 | -2.618 | -0.022 | |
P值 | 0.003 | 0.651 | 0.422 | 0.001 | 0.055 | 0.799 | 0.208 | 0.009 | 0.972 |
Table 3 Comparison of absolute counts of IgA,IgE,and lymphocytes between IgAV renal damage and IgAV groups
组别 | 例数 | 总T淋巴细胞(%) | Th/Ts | NK〔M(P25,P75),%〕 | 总B淋巴细胞〔M(P25,P75),%〕 | 总T绝对数〔M(P25,P75)〕 | NK总数〔M(P25,P75)〕 | 总B淋巴细胞计数〔M(P25,P75)〕 | IgA〔M(P25,P75),g/L〕 | IgE 〔M(P25,P75),g/L〕 |
---|---|---|---|---|---|---|---|---|---|---|
IgAV肾损害组 | 97 | 63.6±10.2 | 1.07(0.78,1.32) | 11.30(7.90,18.00) | 21.10(16.19,26.60) | 1 262(843,1 762) | 228(138,362) | 371(260,609) | 2.60(1.93,3.28) | 82.85(29.59,173.50) |
IgAV组 | 97 | 59.4±9.3 | 0.97(0.81,1.30) | 12.45(8.10,18.97) | 25.55(19.53,31.10) | 1 156(724,1 420) | 209(156,333) | 453(324,618) | 2.05(1.53,2.74) | 66.55(32.89,180.00) |
u(t)值 | 3.030a | -0.453 | -0.803 | -3.375 | -1.917 | -0.254 | -1.260 | -2.618 | -0.022 | |
P值 | 0.003 | 0.651 | 0.422 | 0.001 | 0.055 | 0.799 | 0.208 | 0.009 | 0.972 |
变量 | β | SE | Wald χ2值 | P值 | OR值 | 95%CI |
---|---|---|---|---|---|---|
总T淋巴细胞 | -0.023 | 0.023 | 0.991 | 0.059 | 1.164 | (1.001,1.354) |
总B淋巴细胞 | 0.026 | 0.025 | 1.016 | 0.135 | 1.042 | (0.987,1.100) |
IgA | -0.206 | 0.164 | 1.581 | 0.150 | 0.781 | (0.558,1.093) |
IL-2 | 0.934 | 0.391 | 5.695 | 0.018 | 2.715 | (1.186,6.214) |
IL-6 | 0.052 | 0.039 | 1.806 | 0.142 | 1.062 | (0.980,1.152) |
IL-10 | -0.015 | 0.110 | 0.019 | 0.533 | 0.928 | (0.735,1.173) |
IL-17 | -0.105 | 0.040 | 6.720 | 0.015 | 0.904 | (0.833,0.981) |
IFN-γ | -1.712 | 0.428 | 16.004 | <0.001 | 0.163 | (0.065,0.404) |
TNF-α | 0.524 | 0.291 | 3.249 | 0.036 | 1.892 | (1.042,3.434) |
Table 4 Multivariate Logistic regression analysis of factors influencing renal damage in children with IgAV
变量 | β | SE | Wald χ2值 | P值 | OR值 | 95%CI |
---|---|---|---|---|---|---|
总T淋巴细胞 | -0.023 | 0.023 | 0.991 | 0.059 | 1.164 | (1.001,1.354) |
总B淋巴细胞 | 0.026 | 0.025 | 1.016 | 0.135 | 1.042 | (0.987,1.100) |
IgA | -0.206 | 0.164 | 1.581 | 0.150 | 0.781 | (0.558,1.093) |
IL-2 | 0.934 | 0.391 | 5.695 | 0.018 | 2.715 | (1.186,6.214) |
IL-6 | 0.052 | 0.039 | 1.806 | 0.142 | 1.062 | (0.980,1.152) |
IL-10 | -0.015 | 0.110 | 0.019 | 0.533 | 0.928 | (0.735,1.173) |
IL-17 | -0.105 | 0.040 | 6.720 | 0.015 | 0.904 | (0.833,0.981) |
IFN-γ | -1.712 | 0.428 | 16.004 | <0.001 | 0.163 | (0.065,0.404) |
TNF-α | 0.524 | 0.291 | 3.249 | 0.036 | 1.892 | (1.042,3.434) |
[1] | JENNETTE J C, FALK R J, BACON P A,et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides[J]. Arthritis Rheum,2013,65(1):1-11. DOI:10.1002/art.37715. |
[2] | SHI D, CHAN H, YANG X,et al. Risk factors associated with IgA vasculitis with nephritis (Henoch-Schönlein Purpura nephritis) progressing to unfavorable outcomes:a meta-analysis[J]. PLoS One,2019,14(10):e0223218. DOI:10.1371/journal.pone.0223218. |
[3] | LI Y Y, LI C R, WANG G B,et al. Investigation of the change in CD4+ T cell subset in children with Henoch-Schonlein Purpura[J]. Rheumatol Int,2012,32(12):3785-3792. DOI:10.1007/s00296-011-2266-3. |
[4] | OZEN S. EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides[J]. Ann Rheum Dis,2005,65(7):936-941. DOI:10.1136/ard.2005.046300. |
[5] | 中华医学会儿科学分会肾脏学组. 紫癜性肾炎诊治循证指南(2016)[J]. 中华儿科杂志,2017,55(9):647-651. |
[6] | 杨思睿,刘德滢,王晶华,等. IgA血管炎的免疫机制和治疗现状及展望[J].中华实用儿科临床杂志,2016,31(9):641-645.DOI:10.3760/cma.j.issn.2095-428X.2016.09.001. |
[7] | 孙莹莹,刘霞,黄岩杰. 辅助T淋巴细胞17及白细胞介素-17在过敏性紫癜及紫癜性肾炎发病中的作用[J]. 现代中西医结合杂志,2016,25(5):567-570. DOI:10.3969/j.issn.1008-8849.2016.05.040. |
[8] | DOLFF S, WITZKE O, WILDE B. Th17 cells in renal inflammation and autoimmunity[J]. Autoimmun Rev,2019,18(2):129-136. DOI:10.1016/j.autrev.2018.08.006. |
[9] | TURNER J E, PAUST H J, STEINMETZ O M,et al. The Th17 immune response in renal inflammation[J]. Kidney Int,2010,77(12):1070-1075. DOI:10.1038/ki.2010.102. |
[10] | SCHMIDT T, LUEBBE J, PAUST H J,et al. Mechanisms and functions of IL-17 signaling in renal autoimmune diseases[J]. Mol Immunol,2018,104:90-99. DOI:10.1016/j.molimm.2018.09.005. |
[11] | 陈敏广,林瑞霞,杨青,等. 儿童过敏性紫癜肾炎血清中IFN-γ水平及临床意义[J]. 中国中西医结合肾病杂志,2005,6(11):659-660. |
[12] | RICE E K, NIKOLIC-PATERSON D J, HILL P A,et al. Interferon-gamma induces macrophage migration inhibitory factor synthesis and secretion by tubular epithelial cells[J]. Nephrology,2003,8(3):156-161. DOI:10.1046/j.1440-1797.2003.00152.x. |
[13] | LU H, BAI Y Y, WU L F,et al. Inhibition of macrophage migration inhibitory factor protects against inflammation and matrix deposition in kidney tissues after injury[J]. Mediat Inflamm,2016,2016:1-12. DOI:10.1155/2016/2174682. |
[14] | GÜLHAN B, ORHAN D, KALE G,et al. Studying cytokines of T helper cells in the kidney disease of IgA vasculitis (Henoch-Schönlein Purpura)[J]. Pediatr Nephrol,2015,30(8):1269-1277. DOI:10.1007/s00467-015-3051-4. |
[15] | KAPLANSKY G, BONGRAND P. Cytokines and chemokines[J]. Cell Mol Biol (Noisy-le-grand),2001,47(4):569-574. |
[16] | ZHANG H F, LIANG G B, ZHAO M G,et al. Regulatory T cells demonstrate significantly increased functions following stimulation with IL-2 in a Tim-3-dependent manner in intracranial aneurysms[J]. Int Immunopharmacol,2018,65:342-347. DOI:10.1016/j.intimp.2018.10.029. |
[17] | KAWASAKI Y, SUZUKI J, SAKAI N,et al. Evaluation of T helper-1/-2 balance on the basis of IgG subclasses and serum cytokines in children with glomerulonephritis[J]. Am J Kidney Dis,2004,44(1):42-49. DOI:10.1053/j.ajkd.2004.03.029. |
[18] | 江华,丁甫月,顾龙君. 过敏性紫癜患儿血清IFN-α、IL-2、IL-4、TNF-α水平的变化[J]. 中国当代儿科杂志,2002,4(2):117-118. |
[19] | LI M M, LIU N, ZHAGN M,et al. Clinical significance of serum midkine in children with henoch-schonlein Purpura[J]. Zhongguo Shi Yan Xue Ye Xue Za Zhi,2017,25(1):181-185. DOI:10.7534/j.issn.1009-2137.2017.01.032. |
[20] | MALEK T R. The main function of IL-2 is to promote the development of T regulatory cells[J]. J Leukoc Biol,2003,74(6):961-965. DOI:10.1189/jlb.0603272. |
[21] | 潘凯丽,白庆峰,黄莹,等. 过敏性紫癜患儿血清白细胞介素-4、-6、-8及肿瘤坏死因子-α表达的意义[J]. 实用儿科临床杂志,2007,22(21):1632-1633. |
[22] | 翁小斌,鲍金芳. 过敏性紫癜患儿血清IL-6、IL-12、TFN-α水平变化及临床意义[J]. 浙江医学,2014,36(9):791-792. |
[23] | MAKITA Y, SUZUKI H, KANO T,et al. TLR9 activation induces aberrant IgA glycosylation via APRIL-and IL-6-mediated pathways in IgA nephropathy[J]. Kidney Int,2020,97(2):340-349. DOI:10.1016/j.kint.2019.08.022. |
[24] | 金丽威.白介素10家族研究近况[J].国外医学(免疫学分册),2005,28(4):246-249. |
[25] | WU H T, WEN Y B, YUE C,et al. Serum TNF-α level is associated with disease severity in adult patients with immunoglobulin a vasculitis nephritis[J]. Dis Markers,2020,2020:1-7. DOI:10.1155/2020/5514145. |
[1] | BAI Jiaxin, CHEN Yu, ZHOU Yiheng, LIU Lidi, YANG Rong, YAO Yi, YUAN Bo, ZHANG Yonggang, LEI Yi, ZENG Rui, JIA Yu, LIAO Xiaoyang. Assessment and Treatment of Early-onset Hypertension: Position Statement of the British and Irish Hypertension Association and Its Implications for Clinical Management of Early-onset Hypertension in China [J]. Chinese General Practice, 2025, 28(30): 3741-3746. |
[2] | LYU Juan, LI Yuchuan, CAI Siyu, WANG Chen. Reasons for Seeking Medical Treatment in Endocrinology Department and the Need for Non-medical Intervention in Children with Normal Height: a Qualitative Study [J]. Chinese General Practice, 2025, 28(30): 3766-3772. |
[3] | SHAO Xiaoying, SHAO Jie, ZHU Yan, SHAO Jinling, SHANG Ling, WU Zhenlian, ZHAO Yu, ZHANG Jiacai. Analysis of the Current Status of Iron Deficiency and Factors Affecting Iron Deficiency Anemia among Children Aged 6-36 Months in Guizhou Province [J]. Chinese General Practice, 2025, 28(27): 3368-3374. |
[4] | QUAN Jialin, ZHU Lin, SU Yu, CHEN Zekai, CHEN Ziqi, ZHANG Zhuofan. Research on the Improvement Effect of Exercise Modes on the Executive Function of Overweight or Obese Children or Adolescents: a Network Meta-analysis [J]. Chinese General Practice, 2025, 28(27): 3422-3431. |
[5] | XU Yanpeng, HUANG Pe, ZHANG Pingping, LUO Yan, SHI Xiaoqi, WU Liusong, CHEN Yan, HE Zhixu. Expression of β-Adrenergic Receptors in Acute T-cell Lymphoblastic Leukemia and Its Clinical Significance [J]. Chinese General Practice, 2025, 28(27): 3391-3398. |
[6] | YIN Jiahui, YANG Xinhui, WANG Jingjing, ZHANG Yajing, WANG Lijuan, FU Zuodi, KONG Xiangshuang, GUO Guangxia, LI Yufeng. Predictive Value Waist-to-height Ratio, Waist-to-hip Ratio and Body Mass Index for Metabolic Syndrome [J]. Chinese General Practice, 2025, 28(26): 3258-3263. |
[7] | WEI Jiaohua, PENG Huiru, PENG Jianye, TAN Wenting, HUANG Jine, FANG Li. Expression of the Serum MOTS-c and Its Correlation with Atrial Remodeling in Patients with Atrial Fibrillation [J]. Chinese General Practice, 2025, 28(26): 3271-3276. |
[8] | LI Jiaxin, LIU Zhonghui, XIE Shuo, FU Zhifang, SUN Dan, JIAO Hongmei. Trajectory in Biomarkers of Metabolic and Inflammatory States as Early Predictors of Chronic Critical Illness in Aging Patients [J]. Chinese General Practice, 2025, 28(24): 2993-2999. |
[9] | NA Feiyang, YANG Yi, WANG Yong, WANG Yannan. Study on the Etiology of Chronic Cough in Children Aged 0-14 Years in Lanzhou from 2014 to 2023 [J]. Chinese General Practice, 2025, 28(24): 3026-3031. |
[10] | JIANG Shihua, ZHU Zheng, REN Yingying, ZHU Yaolei, WANG Yue, GAO Xibin. Meta Analysis of the Prevalence and Risk Factors of Myopia in Chinese Children and Adolescents [J]. Chinese General Practice, 2025, 28(24): 3043-3052. |
[11] | DU Qiongliang, LIN Bailang, GUO Honghua. Research Progress and Implications of Group Well-child Care [J]. Chinese General Practice, 2025, 28(21): 2672-2678. |
[12] | LUO Jinping, SUN Jiaying, MOU Yifan, GENG Minghui, ZHANG Baoxuan, WANG Kang, YIN Wenqiang, CHEN Zhongming, MA Dongping. Quantitative Evaluation of China's Pediatric Drug Policies Based on Policy Modeling Consistency Index Model [J]. Chinese General Practice, 2025, 28(21): 2652-2660. |
[13] | HU Wanqin, YU Shenyan, CAO Xuehua, XIANG Feng, JIA Yu. Factors Associated with Precocious Puberty in Chinese Children: a Meta-analysis [J]. Chinese General Practice, 2025, 28(21): 2661-2671. |
[14] | GUO Yi, HAN Xuanye, LIU Zhaojun, JIANG Yaoyao, FU Yang, SHI Lei, ZHAO Shihong. Construction of a Medical Transition Intervention Model for Multiple Chronic Diseases in Children Based on the E-Coach Management Model [J]. Chinese General Practice, 2025, 28(20): 2530-2537. |
[15] | LIU Li, HU Ran, KANG Guodong, ZHANG Lei, WANG Zhiguo. Analysis on the Status of 13-Valent Pneumococcal Conjugate Vaccine in Children Born from 2017 to 2022 in Jiangsu Province [J]. Chinese General Practice, 2025, 28(15): 1903-1907. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||